期刊
JOURNAL OF HEMATOLOGY & ONCOLOGY
卷 5, 期 -, 页码 -出版社
BMC
DOI: 10.1186/1756-8722-5-24
关键词
-
资金
- Merck
- Novartis
- Spectrum
Mycosis fungoides (MF) and Sezary Syndrome (SS) represent the most common subtypes of primary Cutaneous T-cell lymphoma (CTCL). Patients with advanced MF and SS have a poor prognosis leading to an interest in the development of new therapies with targeted mechanisms of action and acceptable safety profiles. In this review we focus on such novel strategies that have changed the treatment paradigm of this rare malignancy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据